Deck Review with Exscientia – by Joshua Elkington – Axial

Exscientia, a leading AI drug discovery company, has set its sights on becoming the first to design clinically validated drugs using AI. The company’s presentation deck reveals a robust pipeline of small molecule drugs in various stages of development, including...